Overview Financials News + Filings Key Docs Ownership Insiders |
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 |
Revenue growth | -15.1% | 471.3% | -30.1% | 100.4% | |
Cost of goods sold | 17.9 | 0.0 | 0.0 | 1.6 | 0.8 |
Gross profit | -17.8 | 0.2 | 0.0 | -1.5 | -0.8 |
Gross margin | -12688.1% | 100.0% | 100.0% | -3740.7% | -3912.2% |
Research and development | | 7.2 | 2.3 | | |
General and administrative | 9.5 | 6.8 | 1.2 | 0.6 | 0.2 |
EBIT | -17.8 | -13.8 | -3.5 | -2.1 | -1.0 |
EBIT margin | -12688.1% | -8379.8% | -12047.5% | -5084.9% | -4989.7% |
Pre-tax income | -17.5 | -13.9 | -3.6 | -2.2 | -1.1 |
Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | -17.6 | -13.9 | -3.6 | -2.2 | -1.1 |
Net margin | -12555.1% | -8418.9% | -12387.7% | -5310.9% | -5364.4% |
|
Diluted EPS | ($1.48) | ($1.37) | ($1.33) | ($0.97) | ($0.49) |
Shares outstanding (diluted) | 11.9 | 10.2 | 2.7 | 2.3 | 2.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|